Back to mobile site

Genetic Technologies (GENE) Names Alison Mew as CEO

December 10, 2012 8:17 AM EST
Genetic Technologies Ltd. (NASDAQ: GENE) announced the appointments of Ms. Alison Mew to the position of Chief Executive Officer and Mr. Ben Silluzio as a Non-Executive Director.

Mr. Silluzio specialises in the provision of advice for sophisticated investors, institutional clients and high net worth families in Melbourne, nationally and abroad. Currently, he serves as the managing partner and desk head of RBS Morgans Family Office, and is also a director of Private Branded Beverages Ltd., a public unlisted company, and is a former President and Chairman of the Italian Chamber of Commerce. Previously, Mr. Silluzio has held several senior positions in the stockbroking and funds management industries, including: Director of UBS Wealth Management Australia, Senior Vice President of Credit Suisse First Boston in Melbourne, Vice President and member of the "Smith Barney Century Council" at Citigroup Smith Barney in Melbourne and as an institutional client advisor at Colonial Institutional Stockbroking in Sydney and Melbourne.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Management Changes

Related Entities

Credit Suisse, UBS, Citi